Publications by authors named "Jeffrey A How"

Claim this Profile
M
Mesonephric-like Adenocarcinoma (MLA) Diagnostic Criteria and Controversies: Perspectives and Guidance From Pathologists in the MLA Consortium.
Anne M Mills, Elizabeth D Euscher, W Glenn McCluggage, Jelena Mirkovic, Kay J Park, Jeffrey A How, Brooke E Howitt

Int J Gynecol Pathol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Photodynamic therapy: An alternative technique to cervical conization for cervical dysplasia.
Jeffrey A How, Amir A Jazaeri

Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival outcomes comparing minimally invasive versus open cytoreductive surgery in recurrent adult-type granulosa cell tumors.
Allison L Brodsky, Alejandra Flores Legarreta, Jeffrey A How, Veena Vuttaradhi, Anil K Sood

Am J Obstet Gynecol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mesonephric-like adenocarcinoma of the female genital tract: Pathologic diagnosis, clinical outcomes, and novel therapeutics.
Kari L Ring, Anne M Mills, Brooke E Howitt, Rachel N Grisham, Elizabeth D Euscher, Jeffrey A How

Gynecol Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab in Patients with Advanced Miscellaneous Rare Cancers: Results from a Phase 2 Basket Trial.
Mirella Nardo, Camila Braganca Xavier, Bettzy Stephen, Jeffrey A How, Justin Moyers

J Immunother Precis Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab plus chemotherapy in frontline treatment of advanced ovarian cancer: Clinical and translational results from a phase 2 trial.
Jeffrey A How, Minghao Dang, Sanghoon Lee, Bryan Fellman, Shannon N Westin

Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating CTLA-4/PD-1 blockade into cervical cancer management: Results of COMPASSION-16.
Jeffrey A How, Amir A Jazaeri

Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Translating biological insights into improved management of endometrial cancer.
Jeffrey A How, Amir A Jazaeri, Shannon N Westin, Barrett C Lawson, Ann H Klopp

Nat Rev Clin Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase Ib Study of Selinexor in Combination with Pembrolizumab in Patients with Metastatic Melanoma.
Mohamed A Gouda, Bettzy Stephen, Yanyan Tian, Anas Alshawa, Dilichukwu O Chudy Onwugaje, Jeffrey Andrew How

J Immunother Precis Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy in locally advanced cervical cancer: Integrating KEYNOTE-A18 into management strategies.
Jeffrey A How, Amir A Jazaeri

Med· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serial cytoreductive surgery and survival outcomes in recurrent adult-type ovarian granulosa cell tumors.
Jeffrey A How, Alejandra Flores Legarreta, Katelyn F Handley, Bryan Fellman, Katherine I Foster

Am J Obstet Gynecol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Obesity is associated with improved progression-free survival in Microsatellite-Instability-High endometrial cancer treated with pembrolizumab.
Laurence Bernard, Jeffrey A How, Shrina Patel, Melinda S Yates, Amir Jazaeri

Gynecol Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes of leuprolide acetate in the treatment of recurrent ovarian granulosa cell tumors.
Katherine I Foster, Alejandra Flores Legarreta, Rhea Kamat, Katelyn F Handley, Deanna Glassman, Jeffrey A How

Am J Obstet Gynecol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exceptional Response to Pembrolizumab for Treatment of Metastatic Chemorefractory Endometrial Carcinoma in a Patient with Lynch Syndrome: A Case Report.
Samantha Batman, J Alejandro Rauh-Hain, Michaela Onstad Grinsfelder, Ross Harrison, Monica Avila, Jeffrey Andrew How

Case Rep Oncol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lymphatic Mapping and Sentinel Node Biopsy in High-Grade Uterine Cancers.
Jeffrey A How, Michael Frumovitz, Katherine I Stewart, Pamela T Soliman

Curr Oncol Rep· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Outcomes of Patients with Recurrent Microsatellite-Stable Endometrial Cancer in Early-Phase Immunotherapy Clinical Trials.
Jeffrey A How, Amir A Jazaeri, Siqing Fu, Jordi Rodon Ahnert, Jing Gong

Cancers (Basel)· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immuno-Oncology for Gynecologic Malignancies.
Jeffrey A How, Ami Patel, Amir A Jazaeri

Adv Exp Med Biol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sentinel lymph node biopsy in high-grade endometrial cancer: a systematic review and meta-analysis of performance characteristics.
Zibi Marchocki, Maria C Cusimano, Lauren Clarfield, Soyoun Rachel Kim, Rouhi Fazelzad, Jeffrey A How

Am J Obstet Gynecol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toxicity and efficacy of the combination of pembrolizumab with recommended or reduced starting doses of lenvatinib for treatment of recurrent endometrial cancer.
Jeffrey A How, Shrina Patel, Bryan Fellman, Karen H Lu, Patrick Hwu

Gynecol Oncol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The clinical efficacy and safety of single-agent pembrolizumab in patients with recurrent granulosa cell tumors of the ovary: a case series from a phase II basket trial.
Jeffrey A How, Amir Jazaeri, Shannon N Westin, Anil K Sood, Lois M Ramondetta

Invest New Drugs· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-operative gastroparesis following carbohydrate loading in a diabetic patient.
Jeffrey A How, Jean Hansen Siedel, Aaron Shafer

Gynecol Oncol Rep· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab in vaginal and vulvar squamous cell carcinoma: a case series from a phase II basket trial.
Jeffrey A How, Amir A Jazaeri, Pamela T Soliman, Nicole D Fleming, Jing Gong

Sci Rep· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modification of Homologous Recombination Deficiency Score Threshold and Association with Long-Term Survival in Epithelial Ovarian Cancer.
Jeffrey A How, Amir A Jazaeri, Bryan Fellman, Molly S Daniels, Suzanna Penn

Cancers (Basel)· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sentinel lymph node mapping in endometrial cancer: a systematic review and meta-analysis.
Jeffrey A How, Patrick O'Farrell, Zainab Amajoud, Susie Lau, Shannon Salvador, Emily How

Minerva Ginecol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of qualitative research on gynaecologic oncology guidelines.
Jeffrey Andrew How, Jeremie Abitbol, Susie Lau, Walter Henri Gotlieb, Haim Arie Abenhaim

J Obstet Gynaecol Can· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis